Schwangerschaftsprotein 1 (SP1) as a maternal serum marker for Down syndrome in the first and second trimesters

Prenatal Diagnosis

Volumn 17, Issue 2, 1997, Pages 101-108

  Qin, Q P ^a   Christiansen, M ^a   Nguyen, T H ^b   Sorensen S ^b   Larsen, S O ^c   Norgaard Pedersen B ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Statens Seruminstitut ^*  (Denmark)

Author keywords

Down syndrome; Pregnancy specific 1 glycoprotein; Prenatal diagnosis; Serum screening in first trimester; Time resolved immunofluorescence

Indexed keywords

MARKER; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICS;

DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; FLUOROIMMUNOASSAY; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY-SPECIFIC BETA 1-GLYCOPROTEINS; PRENATAL DIAGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0031043971     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199702)17:2<101::AID-PD4>3.0.CO;2-H     Document Type: Article

References (27)

1. Altman, D.G. (1991). Practical Statistics for Medical Research, 1st edn, London: Chapman & Hall, 139.
2. 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome, Hum. Genet., 80, 46-48.
3. Bartels, I., Thiele, M., Bogart, M.H. (1990). Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy, Am. J. Med. Genet., 37, 261-264.
4. Bartels, I., Bockel, B., Caesar, J., Krawczak, M., Thiele, M., Rauskolb, R. (1994). Risk of fetal Down's syndrome based on maternal age and varying combinations of maternal serum markers, Arch. Gynecol. Obstet., 255, 57-64.
5. Bersinger, N.A., Brizot, M.L., Johnson, A., Snijders, R.J., Abbott, J., Schneider, H., Nicolaides, K.H. (1994). First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies, Br. J. Obstet. Gynaecol., 101, 970-974.
6. Bohn, H. (1979). Placental and pregnancy proteins. In: Lehmann, F.G. (Ed.). Carcino-embryonic Proteins, Vol. 1, Amsterdam: Elsevier, 289-299.
7. Bohn, H., Chard, T., Grudzinskas, J.G., Klopper, A., Rosen, S., Schultz-Larsen, P., Seppäla, M., Sizaret, P., Tatarinov, Y.S., Teisner, B. (1980). Reference preparation for assay of some pregnancy and cancer associated proteins, Lancet, ii, 796.
8. Brambati, B., Lanzani, A., Tului, L. (1991). Ultrasound and biochemical assessment of first trimester pregnancy. In: Chapman, M., Grudzinskas, G., Chard, T. (Eds). The Embryo, London: Springer-Verlag, 181-194.
9. Brambati, B., Chard, T., Grudzinskas, J.G., Macintosh, M.C.M., Lanzani, A., Bonacchi, I. (1992). Potential first trimester biochemical screening tests for chromosome anomalies, Prenat. Diagn., 12 (Suppl), S4.
10. Brock, D.J.H., Barron, L., Holloway, S., Liston, W.A., Hillier, S.G., Seppäla, M. (1990). First-trimester maternal serum biochemical indicators in Down syndrome, Prenat. Diagn., 10, 245-251.
11. Cuckle, H. (1994). Screening at 11-14 weeks of gestation: the role of established markers and PAPP-A. In: Grudzinskas, J.G., Chard, T., Chapman, M., Cuckle, H. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge University Press, 311-324.
12. Dimitriadou, F., Phocas, I., Mantzavinos, T., Sarandakou, A., Rizos, D., Zourlas, P.A. (1992). Discordant secretion of pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin by human pre-embryos cultured in vitro, Fertil. Steril., 57, 631-636.
13. Graham, G.W., Crossley, J.A., Aitken, D.A., Connor, J.M. (1992). Variation in the levels of pregnancy-specific beta-1-glycoprotein in maternal serum from chromosomally abnormal pregnancies, Prenat. Diagn., 12, 505-512.
14. Johnson, M.R., Riddle, A.F., Grudzinskas, J.G., Sharma Collins, W.P., Nicolaides, K.H. (1993). Reduced circulating placental protein concentrations during the first trimester are associated with preterm labour and low birth weight, Hum. Reprod., 8, 1942-1947.
15. Knight, G.J., Palomaki, G.E., Haddow, J.E., Johnson, A.M., Osathanondh, R., Canick, J.A. (1989). Maternal serum levels of the placental products hCG, hPL, SP1 and progesterone are all elevated in cases of fetal Down syndrome, Am. J. Hum. Genet., 45, A263.
16. Lenton, E.A., Grudzinskas, J.G., Gordon, Y.B., Chard, T., Cooke, I.D. (1981). Pregnancy-specific beta 1-glycoprotein and chorionic gonadotrophin in early pregnancy, Acta Obstet. Gynecol. Scand., 60, 489-492.
17. Macintosh, M.C.M. (1994). Schwangerschaftsprotein 1 (SP1) and biochemical screening for Down's syndrome. In: Grudzinskas, J.G., Chard, T., Chapman, M., Cuckle, H. (Eds). Screening for Down's Syndrome, Cambridge: Cambridge University Press, 171-180.
18. Macintosh, M.C.M., Brambati, B., Chard, T., Grudzinskas, J.G. (1993). First-trimester maternal serum schwangerschaftsprotein 1 (SP1) in pregnancies associated with chromosomal anomalies, Prenat. Diagn., 13, 563-568.
19. McLenachan, P.A., Rutherfurd, K.J., Beggs, K.T., Sims, S.E., Mansfield, B.C. (1994). Characterization of the PSG11 gene, Genomics, 22, 356-363.
20. Petrocik, E., Wassman, E.R., Lee, J.J., Kelly, J.C. (1990). Second trimester maternal serum pregnancy specific beta-1 glycoprotein (SP-1) levels in normal and Down syndrome pregnancies, Am. J. Med. Genet., 37, 114-118.
21. Schultz-Larsen, P., Herz, J.B. (1978). Predictive value of pregnancy-specific beta 1 glycoprotein in threatened abortion, Eur. J. Obstet. Gynecol. Reprod. Biol., 8, 253-257.
22. 1) in normal and pathological pregnancies, and its clinical value compared to human chorionic somatomammotropin (hCS), Acta Obstet. Gynecol. Scand., 57, 193-201.
23. Sørensen, S., Momsen, G., Ruge, S., Pedersen, J.F. (1995). Differential increase in the maternal serum concentrations of the placenta proteins human chorionic gonadotrophin, pregnancy-specific beta 1-glycoprotein, human placental lactogen and pregnancy-associated plasma protein A during the first half of normal pregnancy, elucidated by means of a mathematical model, Hum. Reprod, 10, 453-458.
24. Spencer, K. (1991). Pregnancy specific beta 1 glycoprotein in Down's syndrome screening: does it have any value? Proceedings of the ACB Meeting, Ann. Clin. Biochem., C46, 108.
25. Streydio, C., Swillens, S., Georges, M., Szpirer, C., Vassart, G. (1990). Structure, evolution and chromosomal localization of the human pregnancy-specific beta 1-glycoprotein gene family, Genomics, 7, 661-662.
26. 1 glycoprotein: the effect on measurement by radioimmunoassay and electroimmunoassay, J. Immunol. Methods, 31, 141-149.
27. Wald, N.J., Cuckle, H.S., Densem, J.W. (1989). Maternal serum specific β1-glycoprotein in pregnancies associated with Down's syndrome, Lancet, 2, 450.